EuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

Marine Biotechnology is a premier journal published by Springer, specializing in the interdisciplinary research at the intersection of marine biology and biotechnology. With an ISSN of 1436-2228 and a robust e-ISSN of 1436-2236, this journal has been a cornerstone for scholars and practitioners since its inception in 1999, and is positioned to continue shaping the field through 2024. Recognized for its contributions in Aquatic Science and Biotechnology, it currently holds a Q2 ranking in both categories for 2023, highlighting its relevance and impact within the global scientific community. With a Scopus rank of 64/247 in Aquatic Science and 149/311 in Biotechnology, Marine Biotechnology offers a vital platform for disseminating cutting-edge research that encompasses environmental sustainability, pharmaceutical applications, and bioinformatics. The journal promotes open access to its valuable content, ensuring that research is readily available to a wide audience. By bringing together leading researchers and fostering collaborations, Marine Biotechnology stands as an essential resource for those committed to advancing our understanding of marine resources and their applications in biotechnology.

AIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

Vavilovskii Zhurnal Genetiki i Selektsii, with ISSN 2500-0462 and E-ISSN 2500-3259, is a distinguished open-access journal published by the Russian Academy of Sciences, Institute of Cytology and Genetics. Since transitioning to open access in 2013, the journal has been dedicated to advancing research and discourse in the fields of genetics and selection, particularly within agricultural and biological sciences. With a current ranking of Q2 in Agricultural and Biological Sciences and Q3 in Biochemistry, Genetics and Molecular Biology according to Scopus, it serves as a pivotal platform for researchers, professionals, and students to disseminate their findings and collaborate on innovative ideas. The journal, housed in the vibrant academic environment of Novosibirsk, Russia, publishes a diverse range of articles that contribute to the ongoing evolution of genetic studies and practical applications in agriculture. Its commitment to quality and accessibility ensures it plays an essential role in the global scientific community, fostering knowledge that bridges theoretical research and practical implementation.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

Current Research in Biotechnology is a leading journal published by Elsevier, dedicated to the dissemination of high-quality research in the rapidly evolving field of biotechnology. With an ISSN of 2590-2628, this journal has garnered a reputation for its insightful contributions, currently holding a prestigious Q2 ranking in the Biotechnology category, and placing in the 66th percentile within the Scopus rankings for Biochemistry, Genetics, and Molecular Biology. Running from 2019 and set to continue through 2024, the journal aims to provide a platform for groundbreaking studies that advance our understanding and application of biotechnological innovations. Although it operates under a subscription model, the journal ensures that research impacts a wide audience, facilitating collaboration among researchers, professionals, and students across the globe. By focusing on a diverse range of topics within biotechnology, Current Research in Biotechnology is committed to cultivating a vibrant discourse and fostering advancements that address critical challenges in health, agriculture, and environmental sustainability.

Current Opinion in Biotechnology, published by Elsevier Science Ltd, is a premier academic journal dedicated to providing critical insights and evaluations on emerging trends and developments in the ever-evolving fields of biotechnology and bioengineering. With an impressive impact factor and ranking in the Q1 quartile across bioengineering, biomedical engineering, and biotechnology, this journal serves as an indispensable resource for researchers, professionals, and students alike. Spanning from 1990 to 2024, the journal facilitates scholarly discourse by featuring concise reviews authored by leading experts, covering cutting-edge topics and innovative technologies. With a strong presence in renowned databases such as Scopus, where it ranks within the top percentiles in multiple categories, Current Opinion in Biotechnology not only contributes to the academic community but also impacts industry practices, making it a highly relevant platform for those looking to stay at the forefront of biotechnology innovation.

NATURE METHODS, published by NATURE PORTFOLIO, is a prestigious journal at the forefront of publishing influential research in the disciplines of Biochemistry, Biotechnology, Cell Biology, and Molecular Biology. With a high impact factor and its exemplary Q1 rankings across various categories in 2023, this journal epitomizes excellence, providing a vital platform for researchers and professionals to disseminate groundbreaking methodologies and innovative techniques that drive scientific advancement. Established in 2004 and continuing through to 2024, NATURE METHODS encompasses a diverse array of research articles, reviews, and commentary, making it an essential resource for anyone involved in the biological sciences. While the journal is not currently open access, its contributions are invaluable, offering insights that not only elevate academic discourse but also enhance experimental practice and technological application. Its influence and rigorous peer review process ensure it remains a cornerstone in the rapidly evolving fields of biochemistry and molecular biology.